Srn Advisors, LLC Mckesson Corp Transaction History

Srn Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jun 14, 2024	SELL	$437.42 - $470.64 $1.22 Million - $1.32 Million	-2,799 Closed	0 $0
Q3 2023 Jun 14, 2024	BUY	$402.4 - $446.42 $35,411 - $39,284	88 Added 3.25%	2,799 $1.22 Billion
Q2 2023 Jun 14, 2024	SELL	$354.01 - $427.31 $19,824 - $23,929	-56 Reduced 2.02%	2,711 $1.16 Billion
Q1 2023 Jun 14, 2024	SELL	$335.35 - $386.06 $5,030 - $5,790	-15 Reduced 0.54%	2,767 $990 Million
Q4 2022 Jun 14, 2024	SELL	$346.68 - $397.58 $283,930 - $325,618	-819 Reduced 22.74%	2,782 $1.04 Billion
Q3 2022 Jun 14, 2024	SELL	$321.25 - $373.84 $418,267 - $486,739	-1,302 Reduced 26.56%	3,601 $1.22 Billion
Q2 2022 Jun 14, 2024	SELL	$300.57 - $336.42 $245,866 - $275,191	-818 Reduced 14.3%	4,903 $1.6 Billion
Q1 2022 Jun 14, 2024	BUY	$244.61 - $310.48 $20,302 - $25,769	83 Added 1.47%	5,721 $1.75 Billion
Q4 2021 Jun 14, 2024	BUY	$198.21 - $248.9 $1.12 Million - $1.4 Million	5,638 New	5,638 $1.4 Billion

1,689

109M

1.66M

968K

Ticker MCK
Exchange NYSE
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 143,730,000
Market Cap $89.3B
Description
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...

Get notified when there are updates to the investment portfolio of Srn Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Srn Advisors, LLC with notifications on news.